Enhanced hematopoiesis in sublethally irradiated mice treated with various quinolones

European Journal of Haematology

Volumn 58, Issue 2, 1997, Pages 92-98

  Shalit, I ^a   Kletter, Y ^b   Weiss, K ^b   Gruss, T ^b   Fabian, I ^b  

^a TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cyclopropyl moiety; Hematopoiesis; Quinolones

Indexed keywords

CIPROFLOXACIN; CLINAFLOXACIN; FLEROXACIN; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 3; NORFLOXACIN; OFLOXACIN; POKEWEED MITOGEN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPARFLOXACIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ERYTHROPOIESIS; GROWTH STIMULATION; HEMATOPOIESIS; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SURVIVAL; WHOLE BODY RADIATION;

EID: 0030932635     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1997.tb00930.x     Document Type: Article

References (21)

1. BLEIBERG I, RIKLIS I, FABIAN I. Enhanced resistance of bone-marrow transplanted mice to bacterial infection induced by recombinant granulocyte-macrophage colony-stimulating factor. Blood 1990: 75: 1262-1266.
2. CHU DTW, FERNANDES PB. Structure-activity relationships of the fluoroquinolones. Antimicrob Agents Chemother 1989: 33: 131-135.
3. DESIMONE C, BANDINELLI L, FERRAZZI M, DE SANTIS S, PUGNALONI L, SORICE F. Influence of ofloxacin, norfloxacin, malidixic acid, pyromidic acid and pipemidic acid on human gamma-interferon production and blastogenesis. J Antimicrob Chemother 1986: 17: 811-814.
4. DOMAGALA JM. Structure-activity and structure-side-effect relationships for the quinolone antibacterials. J Antimicrob Chemother 1994: 33: 685-706.
5. FABIAN I, KLETTER Y, SLAVIN S. The therapeutic potential of recombinant granulocyte-macrophage colony stimulating factor and interleukin-3 in murine B cell leukemia. Blood 1988: 72: 913-918.
6. GAMELLI RL, HE L, LIU H. Marrow granulocyte-macrophage progenitor cell response to burn injury as modified by endotoxin and indomethacin. J Trauma, 1994: 37: 339-346.
7. HOOPER DC, WOLFSON JS. Fluoroquinolone antimicrobial agents. N Engl J Med 1991: 324: 384-394.
8. IMRIE K, HALAPY H, COUTURE F, KEATING A. Accelerated neutrophil recovery with ciprofloxacin prophylaxis after autologous bone marrow transplantation (abstr). Blood 1992: 80: 339a.
9. KLETTER Y, RIKLIS I, SHALIT I, FABIAN I. Enhanced repopulation of murine hematopoietic organs in sublethally irradiated mice after treatment with ciprofloxacin. Blood 1991: 78: 1685-1691.
10. LEW M, KEHOE K, RITZ J, et al. Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of infections in bone marrow transplant recipients: a randomized, controlled trial. J Clin Oncol 1993: 13: 239-244.
11. MAXWELL A, GAFFIN SL, WELLS MT. Radiotherapy, endotoxaemia, and nausea. Lancet 1985, 1986: I: 1148-1149.
12. METCALF D, JOHNSON GR. Production by spleen and lymph node cells of conditioned medium with erythroid and other hemopoietic colony-stimulating activity. J Cell Physiol 1978: 96: 31-42.
13. NEU HC. An update of fluoroquinolones. Curr Opin Infect Dis 1992: 5: 755-763.
14. NITSCHE D, SCHULZE C, OESSER S, DALHOFF A, SACK M. The effects of different types of antimicrobial agents on plasma endotoxin activity in Gram-negative bacterial infection. In: GARRARD C, ed. Ciprofloxacin i.v. - defining its role in serious infections. Springer-Verlag, New York Inc., 1994.
15. RIESBECK K, ANDERSSON J, GULBERG M, FORSGREN A. Fluorinated 4 quinolones induce hyperproduction of interleukin-2. Proc Natl Acad Sci USA 1989: 86: 2809-2813.
16. RIESBECK K, FORSGREN A. Increased interleukin 2 transcription in murine lymphocytes by ciprofloxacin. Immunopharmacology 1994: 27: 155-164.
17. RIESBECK K, FORSGREN A. CP-115, 953 stimulates cytokine production by lymphocytes. Antimicrob Agents Chemother 1994: 39: 476-483.
18. ROCHE Y, FAY M, GOUGEROT-POCIDALO MA. Enhancement of interleukin-2 production by quinolone-treated human mononuclear leukocytes. Int J Immmunopharmacol 1988: 10: 161-167.
19. RUBINSTEIN E, SHALIT I. Effect of the quinolones on the immune system. In: HOOPER DC, WOLFSON JS eds. Quinolone antimicrobial agents. Washington: ASM, 1993: 519-526.
20. YAMASHITA Y, ASHIZAWA T, MORIMOTO M, HOSOMI J, NAKANO H. Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. Cancer Res 1992: 52: 2818-2822.
21. ZEHAVI-WILNER T, SHALIT I. Enhancement of interleukin-2 production in human lymphocytes by two new quinolone derivatives. Lymph Res 1989: 8: 35-46.